Concussion Alliance Interview

Sep 2

Concussion Alliance Interviews the CEO of Oxeia, Michael Wyand and co-founder and chief scientific officer, Dr. Vishal Bansal on the company’s work developing a drug treatment for concussion.

Read Part 1 | Read Part 2

John Hauschildt https://www.RumDoodle.com

Concussion Alliance Interview

News Release: Oxeia announces initiation of Phase 2 trial for OXE103

The Hill: Mild Traumatic Brain Injuries Can Lead to a Lifetime of Health Issues for Soldiers